KRSA

Korsana Biosciences, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$31.25

Price (1 Year)

$43.05 $7.7

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %0 / %30
Non-compliant assets / Total market cap %238.1 / %30
Non-compliant revenue / Total incomeNo data

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Korsana Biosciences, Inc. develops therapeutic antibodies for the treatment of neurodegenerative diseases. The company has developed Therapeutic Targeting (THETA), a blood-brain barrier-penetrant shuttle platform designed to enhance central nervous system exposure of investigational therapies and enable delivery of large therapeutic molecules across the blood-brain barrier into the central nervous system.

Website

Analysis (Turkish): KRSA Hissesi Caiz mi, Helal mi? Korsana Biosciences, Inc. Katılım Analizi